Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma

M Rosellini, A Marchetti, V Mollica, A Rizzo… - Nature Reviews …, 2023 - nature.com
The therapeutic algorithm of renal cell carcinoma has been revolutionized by the approval of
immunotherapy agents by regulatory agencies. However, objective and durable responses …

miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses

MS Elballal, AAM Sallam, AE Elesawy… - … -Research and Practice, 2023 - Elsevier
Renal cell carcinoma (RCC) has the highest mortality rate of all genitourinary cancers, and
its prevalence has grown over time. While RCC can be surgically treated and recurrence is …

A novel cuproptosis-related prognostic gene signature and validation of differential expression in clear cell renal cell carcinoma

Z Bian, R Fan, L Xie - Genes, 2022 - mdpi.com
Clear cell renal cell carcinoma (ccRCC) is the most prevalent subtype of renal cell
carcinoma, which is characterized by metabolic reprogramming. Cuproptosis, a novel form …

HO‐1 contributes to luteolin‐triggered ferroptosis in clear cell renal cell carcinoma via increasing the labile iron pool and promoting lipid peroxidation

S Han, F Lin, Y Qi, C Liu, L Zhou, Y Xia… - Oxidative Medicine …, 2022 - Wiley Online Library
Ferroptosis, a novel form of regulated cell death characterized by disrupted iron metabolism
and the accumulation of lipid peroxides, has exhibited enormous potential in the therapy of …

[HTML][HTML] Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies

C Wang, S Dai, X Zhao, Y Zhang, L Gong, K Fu… - Biomedicine & …, 2023 - Elsevier
Celastrol is a pentacyclic triterpenoid extracted from the traditional Chinese medicine
Tripterygium wilfordii Hook F., which has multiple pharmacological activities. In particular …

LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma

Y Wang, YC Feng, Y Gan, L Teng, L Wang, T La… - Journal of Experimental …, 2022 - Springer
Background Distant metastasis is the major cause of clear cell renal cell carcinoma (ccRCC)-
associated mortality. However, molecular mechanisms involved in ccRCC metastasis …

Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review

AKA Lalani, DYC Heng, NS Basappa… - Therapeutic …, 2022 - journals.sagepub.com
Background: Renal cell carcinoma (RCC) is a common malignancy with approximately 30%
of cases diagnosed at the advanced or metastatic stage. While single-agent vascular …

The evolving view of thermogenic fat and its implications in cancer and metabolic diseases

X Yin, Y Chen, R Ruze, R Xu, J Song… - Signal Transduction and …, 2022 - nature.com
The incidence of metabolism-related diseases like obesity and type 2 diabetes mellitus has
reached pandemic levels worldwide and increased gradually. Most of them are listed on the …

Combination treatment with FAAH inhibitors/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the …

J Hao, Q Chen, Y Feng, Q Jiang, H Sun, B Deng… - Cell Death & …, 2023 - nature.com
Ferroptosis, a nonapoptotic form of programmed cell death characterized by significant iron-
dependent peroxidation of phospholipids, is regulated by cellular metabolism, redox …

Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy

J Meng, A Jiang, X Lu, D Gu, Q Ge, S Bai, Y Zhou… - iMeta, 2023 - Wiley Online Library
Clear cell renal cell carcinoma (ccRCC) is a heterogeneous tumor with different genetic and
molecular alterations. Schemes for ccRCC classification system based on multiomics are …